BROOMFIELD, Colo., March 4, 2022 / – Alio™, a medical technology company reinventing the management of chronic disease, announced today David Kuraguntla, Chief Executive Officer, will be presenting in upcoming investor and clinical-scientific conferences.
Life Science Market Research (LSI) US Meeting
March 15-18. 2022
Dana Point, California
https://www.lifesciencemarketresearch.com/medtech-summit-2022/companies
Charing Cross International Symposium
April 26-28, 2022
London, United Kingdom
MedTech Strategist Innovation Summit
April 26-28, 2022
Dublin, Ireland
https://www.medtechstrategist.com/overview
About Alio
Alio Medical™, a division of Alio, Inc. (Broomfield, CO), is a medical technology company developing SmartPatch™ technology and using artificial intelligence (AI) to monitor multiple chronic indications, including end stage kidney disease (ESKD) patients undergoing hemodialysis. Alio is dedicated to the development of remote monitoring that provides actionable clinical data for a variety of conditions to better target interventions for improved outcomes and reduced hospitalizations.
